REL and cervical carcinoma: While a knockout of c-REL promoted survival of HeLa cells to chemotherapy, expression of the c-REL homolog Xenopus Xrel3 in cervical cancer cells treated with 5 μM cisplatin was shown to result in increased apoptosis [24].